Agravitae Releases World’s First Premier Graviola-Infused, High-End Luxury Skin Care Line

3 years ago

TUSTIN, CA / ACCESSWIRE / June 1, 2022 / Agravitae, an industry-leading supplier and marketer of graviola-infused luxury health, wellness…

Marijuana Company of America, Inc. to Present at LD Micro Invitational XII Conference on June 8, 2022

3 years ago

LOS ANGELES, CA / ACCESSWIRE / June 1, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), operates,…

Moderna to Present at Upcoming Conferences in June 2022

3 years ago

CAMBRIDGE, MA / ACCESSWIRE / June 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development

3 years ago

Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent GlioblastomaABINGDON, OXFORDSHIRE / ACCESSWIRE / June 1, 2022…

Privia Health to Participate in Upcoming Investor Conferences

3 years ago

ARLINGTON, Va., June 01, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), today announced that its management team…

Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System

3 years ago

Featured Image for Royal Biologics Featured Image for Royal BiologicsHACKENSACK, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Royal Biologics (Hackensack,…

ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference

3 years ago

SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief…

Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug

3 years ago

Irvine, CA, June 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a…

Chiesi USA Announces First Analysis from the CAMEO Registry Assessing KENGREAL® (cangrelor) Use and Transition to Oral P2Y12 Inhibitors in Routine Clinical Practice

3 years ago

The CAMEO registry, an ongoing study to provide real-world data on KENGREAL® (cangrelor), has published interim results in the Journal…